241 related articles for article (PubMed ID: 21928422)
1. Retained role of surgery for olfactory neuroblastoma.
Smee RI; Broadley K; Williams JR; Meagher NS; Bridger GP
Head Neck; 2011 Oct; 33(10):1486-92. PubMed ID: 21928422
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM
Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655
[TBL] [Abstract][Full Text] [Related]
3. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Kim DW; Jo YH; Kim JH; Wu HG; Rhee CS; Lee CH; Kim TY; Heo DS; Bang YJ; Kim NK
Cancer; 2004 Nov; 101(10):2257-60. PubMed ID: 15484215
[TBL] [Abstract][Full Text] [Related]
5. Olfactory neuroblastoma: 15 years of experience.
Kondo N; Takahashi H; Nii Y; Nagao J
Anticancer Res; 2012 May; 32(5):1697-703. PubMed ID: 22593448
[TBL] [Abstract][Full Text] [Related]
6. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
[TBL] [Abstract][Full Text] [Related]
7. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
[TBL] [Abstract][Full Text] [Related]
10. Esthesioneuroblastoma: the Northwestern University experience.
Argiris A; Dutra J; Tseke P; Haines K
Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma.
Mishima Y; Nagasaki E; Terui Y; Irie T; Takahashi S; Ito Y; Oguchi M; Kawabata K; Kamata S; Hatake K
Cancer; 2004 Sep; 101(6):1437-44. PubMed ID: 15368332
[TBL] [Abstract][Full Text] [Related]
12. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
[TBL] [Abstract][Full Text] [Related]
14. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
15. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
16. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
[TBL] [Abstract][Full Text] [Related]
17. Treatment modalities and outcomes of olfactory neuroblastoma.
Song CM; Won TB; Lee CH; Kim DY; Rhee CS
Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
[TBL] [Abstract][Full Text] [Related]
18. Aggressive olfactory neuroblastoma invading the oral cavity: report of a rare case and review of the literature.
Sarmento DJ; Henriques ÁC; de Carvalho CH; de Morais Mde L; Costa Ade L; da Silveira ÉJ
J Oral Maxillofac Surg; 2012 Mar; 70(3):e252-7. PubMed ID: 22374068
[No Abstract] [Full Text] [Related]
19. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
